Synthesis and biological evaluation of a novel class of coumarin derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 24, Issue 22, 2014, Pages 5274-5278

  Li, Hong ^a   Wang, Xiaomin ^a   Xu, Guichao ^a   Zeng, Li ^a   Cheng, Kai ^a   Gao, Pengchao ^b   Sun, Qing ^a   Liao, Wei ^a   Zhang, Jianwei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Amino acid; Anti tumor; Coumarin; Cytotoxicity; Peptide

Indexed keywords

7 HYDROXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID TRYPTOPHAN TRYPTOPHAN AA OBZL DERIVATIVE; COUMARIN DERIVATIVE; DOXORUBICIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CALF THYMUS DNA; DNA;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; ANIMAL; BOVINE; CELL SURVIVAL; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECTS; METABOLISM; NEOPLASMS; SYNTHESIS; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; CELL SURVIVAL; CIRCULAR DICHROISM; COUMARINS; DNA; DOXORUBICIN; HUMANS; MICE; NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84908401463     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2014.09.051     Document Type: Article

References (28)

1. F.A. Jimenez-Orozco, J.A. Molina-Guarneros, N. Mendoza-Patino, F. Leon-Cedeno, B. Flores-Perez, E. Santos-Santos, and J.J. Mandoki Melanoma Res. 9 1999 243
2. P. Laurin, D. Ferroud, M. Klich, C. Dupis-Hamelin, P. Mauvais, P. Lassaigne, A. Bonnefoy, and B. Musicki Bioorg. Med. Chem. Lett. 9 1999 2079
3. J.R.S. Hoult, and M. Paya Gen. Pharmacol. 27 1996 713
4. S.P. Pillai, S.R. Menon, L.A. Mitscher, C.A. Pillai, and D.M. Shankel J. Nat. Prod. 62 1999 1358
5. Y. Kimura, H. Okuda, S. Arichi, K. Baba, and M. Kozawa Biochim. Biophys. Acta 834 1985 224
6. J. Homanova, A. Kozubik, L. Dusek, and J. Pachernik Eur. J. Pharmacol. 350 1998 273
7. A. Maucher, M. Kager, and E. Angerer J. Cancer Res. Clin. Oncol. 119 1993 150
8. G.J. Finn, B.S. Creaven, and D.A. Egan Eur. J. Pharm. Sci. 26 2005 16
9. S. Sharma, J.D. Stutzman, G.J. Kellof, and V.E. Steele Cancer Res. 54 1994 5848
10. D. Egan, P. James, D. Cooke, and R. O'Kennedy Cancer Lett. 118 1997 201
11. J.D. Hayes, D.J. Pulford, E.M. Ellis, R. McLeod, R.F.L. James, J. Seidegard, E. Mosialou, B. Jernstrom, and G.E. Neal Chem. Biol. Interact. 111 1998 51
12. G.J. Finn, B.S. Creaven, and D.A. Egan Cancer Lett. 214 2004 43
13. G.J. Finn, B.S. Creaven, and D.A. Egan Biochem. Pharmacol. 67 2004 1779
14. B. Thati, A. Noble, B.S. Creaven, M. Walsh, M. McCann, K. Kavanagh, M. Devereux, and D.A. Egan Cancer Lett. 248 2007 321
15. I. Kostova, I. Manolov, I. Nicolova, S. Konstantinov, and M. Karaivanova Eur. J. Med. Chem. 36 2001 339
16. T.S.B. Baul, W. Rynjah, R. Willem, M. Biesemans, I. Verbruggen, M. Holèapek, D. Vos, and A. Linden J. Organomet. Chem. 689 2004 4691
17. X.Y. Zhang, Y.F. Yang, M. Zhao, L. Liu, M.Q. Zheng, Y.J. Wang, J.H. Wu, and S.Q. Peng Eur. J. Med. Chem. 46 2011 3410
18. N.S. Dighe, S.R. Pattan, S.S. Dengale, D.S. Musmade, M. Shelar, V. Tambe, and M.B. Hole Arch. Appl. Sci. Res. 2 2010 65
19. C.A. Hastings, and J.K. Barton Biochemistry 38 1999 10042
20. H. Han, R.L. de Vrueh, J.K. Rhie, K.M. Covitz, P.L. Smith, and C.P. Lee Pharm. Res. 15 1998 1154
21. M.E. Ganapathy, W. Huang, H. Wang, V. Ganapathy, and F.H. Leibach Biochem. Biophys. Res. Commun. 246 1998 470
22. J.A. Jr, R.L.A. Dias, M.S. Castilho, G. Oliva, and A.G. Corrêa J. Braz. Chem. Soc. 16 2005 763
23. T.A.K. Al-Allaf, and L.J. Rashan Eur. J. Med. Chem. 33 1998 817
24. R. Cao, H. Chen, W. Peng, Y. Ma, X. Hou, H. Guan, X. Liu, and A. Xu Eur. J. Med. Chem. 40 2005 991
25. L.H. Hurley Nat. Rev. Cancer 2 2002 188
26. S. Das, and G.S. Kumar J. Mol. Struct. 872 2008 56
27. M.J.R.P. Queiroz, E.M.S. Castanheir, T.C.T. Lopes, Y.K. Cruz, and G. Kirsch J. Photochem. Photobiol., A 190 2007 45
28. A. Silvestri, G. Barone, G. Ruisi, D. Anselmo, S. Riela, and V.T. Liveri J. Inorg. Biochem. 101 2007 841